Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
The undoing and redoing of the diabetic β-cell
Wei Wang
, Chune Liu
,
Maria Jimenez-Gonzalez
, Woo Jin Song
, Mehboob A. Hussain
Research output
:
Contribution to journal
›
Review article
›
peer-review
15
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The undoing and redoing of the diabetic β-cell'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Diabetic
100%
Cell Mass
100%
Functional Cells
100%
Redo
100%
Type 2 Diabetes Mellitus (T2DM)
66%
Cell Death
33%
Clinical Trials
33%
Cell Apoptosis
33%
Therapeutic Intervention
33%
Therapeutic Potential
33%
Type 1 Diabetes Mellitus (T1DM)
33%
Dedifferentiation
33%
Pharmacotherapy
33%
Insulin Secretion
33%
Rodent Models
33%
Metabolic Stress
33%
Endogenous Cells
33%
Clinical Observation
33%
Intensive Insulin Therapy
33%
Euglycemia
33%
Cell Renewal
33%
Metabolic Stressors
33%
Immunology and Microbiology
Cell Death
100%
Insulin Release
100%
Cell Renewal
100%
Cell Dedifferentiation
100%
Insulin
100%
Programmed Cell Death
100%
Drug Therapy
100%
Neuroscience
Cell Death
100%
Diabetes Mellitus
100%
Insulin Therapy
100%
Cell Dedifferentiation
100%
Cell Renewal
100%
Drug Therapy
100%
Programmed Cell Death
100%
Biochemistry, Genetics and Molecular Biology
Cell Death
100%
Clinical Trial
100%
Insulin Release
100%
Cell Dedifferentiation
100%
Cell Renewal
100%
Programmed Cell Death
100%
Drug Therapy
100%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacotherapy
100%
Clinical Trial
100%
Diabetes Mellitus
100%
Metabolic Stress
100%
Maturity Onset Diabetes of the Young
100%